Skip navigation

Abbott Labs says AbbVie places $14.7B in debt

Abbott Laboratories Inc. said Tuesday its branded drug business priced a $14.7 billion private placement of debt. Full story

S&P downgrades Abbott Labs credit rating

Standard & Poor's Ratings Services lowered Abbott Laboratories Inc.'s credit rating Friday as the company prepares to split in two. Full story

Earnings roundup: Halliburton, Abbott Labs

Among the earnings stories for Wednesday, Oct. 17, from The Associated Press: Full story

News Summary: Abbott Labs hepatitis C drug study

THE JUMP: Shares of Abbott Laboratories Inc. rose Monday after the company said an experimental five-drug regimen cured 99 percent of patients in a 12-week mid-stage clinical trial. Full story

U.S. judge approves $700 million in Abbott Depakote fines, costs

WASHINGTON (Reuters) - A federal judge on Tuesday sentenced Abbott Laboratories Inc to pay $700 million in fines and other costs for illegal marketing of its drug Depakote, in connection with a previously announced settlement, the U.S. Justice Department said. Full story

Cramer: Five Reason to Own Abbott Labs

   In a special Salute to the Troops episode of Mad Money, Jim Cramer introduces his father, Ken Cramer, a World War II veteran, and gives investors five reasons they should protect their portfolios with shares of Abbott Labs.

Sponsored Links
advertisement | ad info